SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >


Add GATA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 5/22/2015 11:11:25 AM - Followers: 33 - Board type: Free - Posts Today: 0


Share Structure

                                                       Market Value                 $11,784,225        a/o July 29, 2011
                                                       Shares Outstanding       47,136,900          a/o June 30, 2011
                                                       Float                              2,171,600           a/o June 30, 2011
                                                       Authorized Shares         100,000,000        a/o June 30, 2011




UPDATE: Groupe Athena, Inc. Continues Pace for Record Fiscal Year With Strong Second

Quarter Sales


MUMBAI, INDIA--(Marketwired - Mar 10, 2014) -  Groupe Athena, Inc. (OTC Pink: GATA) today posted their quarterly results for the three months ending December 31, 2013. The company reported revenues of $17,961,452 which is an increase of 21% when compared to the corresponding period in 2012 and represents the strongest 6 month earnings period in the company's history. Operating income for the quarter was also strong at $3, 097,791, an increase of over 26% from $2.45 million for the same period in 2012.

Net income after taxes and depreciation for the period was $2,083,606 or $.044 per share.

With regard the continued strong growth, the company's President, Ms. D Purohit, stated, "I can't put into words how exciting it is to see our dreams become reality. Our core business is thriving and our expansion plans are proceeding as expected. We fully expect 2014 to be a breakout year for Groupe Athena, Inc."

The company reiterates that the strong increase in operating income is due to the continued increases in gross margins and they anticipate further increases as more work is transitioned in-house. Operating margins are approaching 20% currently and management remains committed to attain 40% gross margins over the next few years.

The company's order position also remains very healthy and management expects record total revenues of at least $65 million for the current fiscal year. 

Cash and cash equivalents are at record levels for the company and continue to grow and debt remains virtually non-existent.

To review the complete quarterly report please go to and click on "Financials."

The Indian pharmaceutical industry is increasingly focusing on exports to the United States and Europe and GATA is well positioned to help them get their products approved by the respective governing bodies for sales in both regions. All of these are potential clients and the Company believes it has an advantage over competitors due to the facilities based in India, and their ability to deliver quick feedback to clients that could result in expedited order generation. With recent additions to equipment, the company will continue to take on additional contracts and continue to anticipate further growth.

About Groupe Athena, Inc.

 The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.

TThe Company's web address is

For more information contact:
Paul Cornell
Corporate Shareholder Relations, Inc.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
GATA News: Groupe Athena, Inc. Posts 2nd Quarter Results 01/28/2015 12:54:00 PM
#1361   Ho Hum. I wish this thing would trade... devnull 05/22/15 11:11:25 AM
#1360   But that never helps... The market really doesn't PennyStalker 04/28/15 08:10:18 AM
#1359   Stock went totally pathetic after that sudden no Axel 04/28/15 08:05:27 AM
#1358   Actually almost 300,000 shares of yesterday's volume was PennyStalker 02/27/15 05:35:33 AM
#1357   Looks like people who got trapped in the Axel 02/26/15 03:35:59 PM
#1356   I've been asking the same questions. The company PennyStalker 02/21/15 03:05:47 PM
#1355   this seeems to be too real to be roby117 02/21/15 12:11:05 PM
#1354   And looking thin NYC Trader 02/19/15 09:32:16 AM
#1353   .20 on the ask!! Mick Dodge 02/19/15 09:26:27 AM
#1352   $GATA website Mick Dodge 02/19/15 09:25:40 AM
#1351   The company has a research and marketing facility 02/19/15 09:14:10 AM
#1350   About Groupe Athena, Inc.: 02/19/15 09:09:55 AM
#1349   $GATA Latest news ( NYC Trader 02/19/15 09:09:42 AM
#1348   Big news this morning again!!! Groupe Athena, Inc. 02/19/15 09:08:46 AM
#1347   $GATA Trader's Cheat Sheet NYC Trader 02/19/15 09:07:52 AM
#1346   At this share price, it is insanely cheap 02/19/15 09:06:43 AM
#1345   Another mammonth revenue update 02/19/15 09:05:59 AM
#1344   That is huge revenues for a pinky. GATA NYC Trader 02/19/15 08:59:33 AM
#1343   $GATA Historical Prices ( NYC Trader 02/19/15 08:58:39 AM
#1342   $GATA charts NYC Trader 02/19/15 08:57:49 AM
#1341   Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS GATA), Mick Dodge 02/19/15 08:50:24 AM
#1340   With offices in India and America, the expert budfoxhub 02/19/15 08:50:14 AM
#1339   The company is a research and testing organization budfoxhub 02/19/15 08:49:30 AM
#1338   The Indian pharmaceutical industry is increasingly focusing on budfoxhub 02/19/15 08:44:48 AM
#1337   Check out the company website Cabroncita 02/19/15 08:44:19 AM
#1336   Groupe Athena, Inc. Issues Update on Atorvastatin Calcium Project: budfoxhub 02/19/15 08:42:50 AM
#1335   The company has a research and marketing facility Cabroncita 02/19/15 08:39:05 AM
#1334   That is fantastic for the company and the Cabroncita 02/19/15 08:36:01 AM
#1333   Ready for big volume today! budfoxhub 02/19/15 08:35:28 AM
#1332   With recent additions to equipment, the company will Mick Dodge 02/19/15 08:34:13 AM
#1331   Recent news Cabroncita 02/19/15 08:34:05 AM
#1330   Good morning everyone!! Mick Dodge 02/19/15 08:33:51 AM
#1329   I have no idea PennyStalker, Very undervalued for Cabroncita 02/19/15 08:31:02 AM
#1328   That's a good question. Extremely undervalued for sure. Traderfan 02/17/15 05:11:15 PM
#1327   I've never seen a Pink sheet with financial PennyStalker 02/17/15 12:25:18 PM
#1326   Low Float: 5.8M (47.1M OS). Could move fast. devnull 02/17/15 09:27:30 AM
#1325   As was previously stated, the Indian pharmaceutical industry 02/17/15 09:09:27 AM
#1324   They had also just announced $1.85m net income 02/17/15 09:08:28 AM
#1323   $GATA web address is Hooka 02/17/15 09:00:40 AM
#1322   The company is on track to report revenue 02/17/15 08:56:43 AM
#1321   $70M revenue!!!!!! MUMBAI, IN / ACCESSWIRE / February 02/17/15 08:53:30 AM
#1320   Such great premarket news! 02/17/15 08:52:33 AM
#1319   Could see a gap this morning! Mick Dodge 02/17/15 08:41:20 AM
#1318   The Company believes it has an advantage over Hooka 02/17/15 08:36:19 AM
#1317   Book value is .4193!! Axel 02/17/15 08:35:58 AM
#1316   Huge news there Hooka, thanks for the link! budfoxhub 02/17/15 08:32:36 AM
#1315   With recent additions to equipment, the company will Hooka 02/17/15 08:30:15 AM
#1314   The company is on track to report revenue Hooka 02/17/15 08:29:14 AM
#1313   Groupe Athena, Inc. Announces Revenue Update Hooka 02/17/15 08:28:39 AM
#1312   I agree Bud, it should hit a lot Cabroncita 02/17/15 08:24:42 AM